Your browser doesn't support javascript.
loading
Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.
Zirakzadeh, A Ali; Kinn, Johan; Krantz, David; Rosenblatt, Robert; Winerdal, Malin E; Hu, Jin; Hartana, Ciputra Adijaya; Lundgren, Christian; Bergman, Emma Ahlén; Johansson, Markus; Holmström, Benny; Hansson, Johan; Sidikii, Alexander; Vasko, Janos; Marits, Per; Sherif, Amir; Winqvist, Ola.
Affiliation
  • Zirakzadeh AA; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Kinn J; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Krantz D; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Rosenblatt R; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden; Department of Urology, Stockholm South General Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Winerdal ME; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Hu J; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Hartana CA; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Lundgren C; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Bergman EA; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Johansson M; Department of Urology, Sundsvall Hospital, Sundsvall, Sweden.
  • Holmström B; Department of Urology, Akademiska University Hospital, Uppsala, Sweden.
  • Hansson J; Centre for Research and Development, Faculty of Medicine, Uppsala University, County Council of Gävleborg, Uppsala, Sweden.
  • Sidikii A; Department of Urology, Länssjukhuset Ryhov, Region Jönköping, Sweden.
  • Vasko J; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Marits P; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden.
  • Sherif A; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden.
  • Winqvist O; Department of Medicine, Unit of Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden. Electronic address: ola.winqvist@karolinska.se.
Clin Immunol ; 176: 63-70, 2017 03.
Article in En | MEDLINE | ID: mdl-28025135
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / B-Lymphocytes / Lymphocyte Activation / CD4-Positive T-Lymphocytes / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2017 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / B-Lymphocytes / Lymphocyte Activation / CD4-Positive T-Lymphocytes / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2017 Type: Article Affiliation country: Sweden